SCHEDULE 13G/A: Capital Research Global Investors Discloses 7.1% Stake in British American Tobacco PLC

Capital Research Global Investors has filed an amended Schedule 13G, revealing a beneficial ownership of 7.1% in British American Tobacco PLC as of December 31, 2024.

Summary

• Capital Research Global Investors (CRGI) reported beneficial ownership of 155,851,331 shares of British American Tobacco PLC's Common Stock.
• This ownership represents 7.1% of the total class of securities, based on 2,209,469,178 shares believed to be outstanding.
• CRGI holds sole voting power over 155,837,377 shares and sole dispositive power over 155,851,331 shares.
• The filing is an Amendment No. 2 to a Schedule 13G, indicating a previous disclosure of ownership.
• The shares reported include 15,594,361 Depository Receipts, which represent an equal number of Common Stock shares.
• Capital Research Global Investors is identified as an Investment Adviser (IA) and is a division of Capital Research and Management Company (CRMC).

Sentiment

Score: 5

Explanation: The document is a factual, regulatory filing disclosing beneficial ownership. It does not contain subjective language or performance data that would indicate a strong positive or negative sentiment. It is neutral in tone and content.

Positives

• The disclosure of a significant stake by a major investment adviser like Capital Research Global Investors can be viewed as a vote of confidence in British American Tobacco PLC's long-term prospects by a sophisticated institutional investor.

Negatives

• This filing is a routine disclosure of beneficial ownership and does not inherently contain negative information about the issuer's performance or outlook.

Risks

• This Schedule 13G filing primarily details beneficial ownership and does not contain specific risk factors related to British American Tobacco PLC's operations or financial health. Risks associated with the investment in British American Tobacco PLC would typically be found in the company's own annual or quarterly reports (e.g., 10-K, 10-Q).

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding British American Tobacco PLC's future performance or strategic outlook. Such information would typically be found in the company's own financial reports.

Management Comments

• Jae Won Chung, Vice President and Senior Counsel II, Capital Research and Management Company, certified that 'to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.'

Industry Context

This filing indicates a significant, passive investment by a major global asset manager in a leading company within the tobacco industry. Such disclosures are routine for institutional investors crossing certain ownership thresholds and provide transparency into large holdings, which can be a signal of long-term investment interest in the sector.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional holding by Capital Research Global Investors may provide a degree of confidence to other shareholders, signaling that a major investor sees value in British American Tobacco PLC.
• Management: Management may view this as a validation of their strategy, knowing a large, passive investor is holding a substantial stake.

Key Dates

Keywords

British American Tobacco PLC, Capital Research Global Investors, SEC Filing, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Tobacco Industry, Investment Adviser